{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:33:56Z","timestamp":1782923636236,"version":"3.54.5"},"reference-count":0,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bras Pneumol."],"abstract":"<jats:p>Alpha-1 antitrypsin deficiency (AATD) is a relatively rare genetic disorder, inherited in an autosomal codominant manner, that results in reduced serum AAT concentrations, with a consequent reduction in antielastase activity in the lungs, as well as an increased risk of diseases such as pulmonary emphysema, liver cirrhosis, and necrotizing panniculitis. It results from different mutations in the SERPINA1 gene, leading to changes in the AAT glycoprotein, which can alter its concentration, conformation, and function. Unfortunately, underdiagnosis is quite common; it is possible that only 10% of cases are diagnosed. The most common deficiency is in the Z variant, and it is estimated that more than 3 million people worldwide have combinations of alleles associated with severe AATD. Serum AAT concentrations should be determined, and allelic variants should be identified by phenotyping or genotyping. Monitoring lung function, especially through spirometry, is essential, because it provides information on the progression of the disease. Although pulmonary densitometry appears to be the most sensitive measure of emphysema progression, it should not be used in routine clinical practice to monitor patients. In general, the treatment is similar to that indicated for patients with COPD not caused by AATD. Exogenous administration of purified human serum-derived AAT is the only specific treatment approved for AATD in nonsmoking patients with severe deficiency (serum AAT concentration of &lt; 57 mg\/dL or &lt; 11 \u00b5M), with evidence of functional loss above the physiological level.<\/jats:p>","DOI":"10.36416\/1806-3756\/e20240235","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T15:56:33Z","timestamp":1732204593000},"page":"e20240235","source":"Crossref","is-referenced-by-count":5,"title":["Recommendations for the diagnosis and treatment of alpha-1 antitrypsin deficiency"],"prefix":"10.36416","author":[{"given":"Paulo Henrique","family":"Ramos Feitosa1","sequence":"first","affiliation":[{"name":"1. Hospital Regional da Asa Norte, Bras\u00edlia (DF) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Vera","family":"Cruz de Oliveira Castellano2","sequence":"additional","affiliation":[{"name":"2. Hospital do Servidor P\u00fablico Estadual de S\u00e3o Paulo \u2013 IAMSPE \u2013 S\u00e3o Paulo (SP) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Henrique da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"da Rocha Oliveira Cardoso4","sequence":"additional","affiliation":[{"name":"4. Hospital das Cl\u00ednicas, Universidade Federal de Goi\u00e1s \u2013 HU-UFG \u2013 Goi\u00e1s (GO) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Fernando","family":"Ferreira Pereira5","sequence":"additional","affiliation":[{"name":"5. Hospital das Cl\u00ednicas \u2013 Universidade Federal de Minas Gerais \u2013 UFMG \u2013 Belo Horizonte ( MG) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico","family":"Leon Arrabal Fernandes6","sequence":"additional","affiliation":[{"name":"6. Divis\u00e3o de Pneumologia, Instituto do Cora\u00e7\u00e3o, Hospital das Cl\u00ednicas, Faculdade de Medicina, Universidade de S\u00e3o Paulo, S\u00e3o Paulo ( SP) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio","family":"Marcelo Costa7","sequence":"additional","affiliation":[{"name":"7. Complexo Hospital das Cl\u00ednicas, Universidade Federal do Paran\u00e1 \u2013 CHC-UFPR \u2013 Curitiba (PR) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Brisot Felisbino8","sequence":"additional","affiliation":[{"name":"8. Hospital Universit\u00e1rio, Universidade Federal de Santa Catarina \u2013 HU-UFSC \u2013 Florian\u00f3polis (SC) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Faria Fran\u00e7a de Oliveira9","sequence":"additional","affiliation":[{"name":"9. Hospital Ot\u00e1vio de Freitas, Secretaria de Sa\u00fade do Estado de Pernambuco, Recife (PE) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose R","family":"Jardim10","sequence":"additional","affiliation":[{"name":"10. Universidade Federal de S\u00e3o Paulo, S\u00e3o Paulo (SP) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Miravitlles11","sequence":"additional","affiliation":[{"name":"11. Vall d\u2019Hebron Institut de Recerca \u2013 VHIR \u2013 Hospital Universit\u00e1rio Valld\u2019Hebron, Barcelona, Espa\u00f1a."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22288","published-online":{"date-parts":[[2024,11,21]]},"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T15:56:34Z","timestamp":1732204594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jornaldepneumologia.com.br\/details\/4016\/en-US"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":0,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20240235","relation":{},"ISSN":["1806-3756"],"issn-type":[{"value":"1806-3756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]}}}